Lewis Sheri 4

What Happened

• Sheri Lewis, Chief Strategy Officer and Chief Operating Officer of Beauty Health Co (SKIN), received a grant of 746,681 restricted stock units (RSUs) on March 20, 2026.
• The filing lists the award (transaction code A); no per-share price or immediate cash value is provided because these are contingent RSUs, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-20; Form 4 filed 2026-03-24 (timely under the two-business-day filing rule).
• Quantity: 746,681 RSUs granted. Price: N/A (RSUs represent future shares, not a cash purchase).
• Shares owned after transaction: not specified in the filing.
• Footnote: Each RSU is a contingent right to one share of Class A common stock. RSUs vest in three equal installments on each of the first three anniversaries of the grant date (Mar 20, 2027; Mar 20, 2028; Mar 20, 2029), subject to continued service and certain acceleration rights.

Context

• RSU grants are a form of compensation and typically vest over time; they do not reflect an immediate buy or sell of stock.
• Vesting and any acceleration provisions determine when the RSUs convert to actual shares that can be sold; this award primarily signals compensation alignment rather than an immediate insider market view.